Signal: LimmaTech raises $37m for antimicrobial resistance research
Limmatech, the GSK spinout focusing on antimicrobial resistance, announced on Monday (9 October) that it has raised $37m in a…
Limmatech, the GSK spinout focusing on antimicrobial resistance, announced on Monday (9 October) that it has raised $37m in a…
The Nobel Prize in Physiology and Medicine has been awarded to two scientists whose research allowed for the development of…